Back

Is COVID-19 seasonal? A time series modeling approach

Wiemken, T. L.; Khan, F.; Nguyen, J. L.; Jodar, L.; McLaughlin, J. M.

2022-06-19 epidemiology
10.1101/2022.06.17.22276570 medRxiv
Show abstract

BackgroundDetermining whether SARS-CoV-2 is or will be seasonal like other respiratory viruses is critical for public health planning, including informing vaccine policy regarding the optimal timing for deploying booster doses. To help answer this urgent public health question, we evaluated whether COVID-19 case rates in the United States and Europe followed a seasonal pattern using time series models. MethodsWe analyzed COVID-19 data from Our World in Data from Mar 2020 through Apr 2022 for the United States (and Census Region) and five European countries (Italy, France, Germany, Spain, and the United Kingdom). For each, anomalies were identified using Twitters decomposition method and Generalized Extreme Studentized Deviate tests. We performed sensitivity analyses to determine the impact of data source (i.e., using US Centers for Disease Control and Prevention [CDC] data instead of OWID) and whether findings were similar after adjusting for multiple covariates. Finally, we determined whether our time series models accurately predicted seasonal influenza trends using US CDC FluView data. ResultsAnomaly plots detected COVID-19 rates that were higher than expected between November and March each year in the United States and Europe. In the US Southern Census Region, in addition to seasonal peaks in the fall/winter, a second peak in Aug/Sep 2021 was identified as anomalous. Results were robust to sensitivity analyses. ConclusionsOur results support employing annual protective measures against SARS-CoV-2 such as administration of seasonal booster vaccines or other non-pharmaceutical interventions in a similar timeframe as those already in place for influenza prevention. Summary of the Main PointAlthough SARS-CoV-2 continues to cause morbidity and mortality year-round due to its high transmissibility and rapid viral evolution, our results suggest that COVID-19 activity in the United States and Europe peaks during the traditional winter viral respiratory season.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Influenza and Other Respiratory Viruses
44 papers in training set
Top 0.1%
28.5%
2
Clinical Infectious Diseases
231 papers in training set
Top 0.5%
8.7%
3
BMC Medicine
163 papers in training set
Top 0.5%
6.6%
4
BMC Infectious Diseases
118 papers in training set
Top 0.5%
5.0%
5
PLOS ONE
4510 papers in training set
Top 37%
3.8%
50% of probability mass above
6
Vaccine
189 papers in training set
Top 0.7%
3.7%
7
Wellcome Open Research
57 papers in training set
Top 0.4%
2.7%
8
Open Forum Infectious Diseases
134 papers in training set
Top 0.7%
2.7%
9
The Journal of Infectious Diseases
182 papers in training set
Top 2%
2.7%
10
International Journal of Infectious Diseases
126 papers in training set
Top 1%
2.1%
11
JAMA Network Open
127 papers in training set
Top 2%
1.9%
12
Scientific Reports
3102 papers in training set
Top 56%
1.7%
13
JMIR Public Health and Surveillance
45 papers in training set
Top 2%
1.7%
14
Journal of Infection
71 papers in training set
Top 1%
1.7%
15
BMC Public Health
147 papers in training set
Top 3%
1.7%
16
Journal of Medical Internet Research
85 papers in training set
Top 3%
1.5%
17
Nature Communications
4913 papers in training set
Top 56%
1.3%
18
The Lancet Infectious Diseases
71 papers in training set
Top 2%
1.1%
19
American Journal of Epidemiology
57 papers in training set
Top 1%
1.0%
20
Frontiers in Public Health
140 papers in training set
Top 7%
0.9%
21
EClinicalMedicine
21 papers in training set
Top 0.8%
0.8%
22
PLOS Computational Biology
1633 papers in training set
Top 24%
0.8%
23
Journal of Travel Medicine
18 papers in training set
Top 0.3%
0.8%
24
American Journal of Preventive Medicine
11 papers in training set
Top 0.6%
0.7%
25
The Lancet Regional Health - Americas
22 papers in training set
Top 0.3%
0.7%
26
International Journal of Medical Informatics
25 papers in training set
Top 2%
0.7%
27
Viruses
318 papers in training set
Top 6%
0.7%
28
Travel Medicine and Infectious Disease
15 papers in training set
Top 0.9%
0.5%
29
Vaccine: X
19 papers in training set
Top 0.4%
0.5%